Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | January 09, 2026 | January 13, 2026 |
| G1 Therapeutics, Inc.GTHX · Entity 87413 | Director | June 23, 2022 | June 24, 2022 |
| Merck & Co., Inc.MRK · Entity 2807 | Exe V-P & Pres. MMD | February 22, 2016 | February 24, 2016 |
| PUBLIC SERVICE ENTERPRISE GROUP INCPEG · Entity 203 | Director | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date January 09, 2026 · Filed January 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,748.066 |
Reported balance
After 2026-01-09 transaction · row 1
1 source rowRow 1 · 2026-01-09 · Grant · Acquired 201.508 · Balance 57,748.066 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
G1 Therapeutics, Inc.
Report date June 23, 2022 · Filed June 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,389 |
Reported balance
After 2022-06-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-06-23 · Grant · Acquired 10,000 · Balance 14,389 F1: Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director. F2: Each RSU represents a contingent right to receive one share of Issuer common stock F3: Represents 4,389 shares of common stock and 10,000 restricted stock units |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.30 · Expires 2032-06-23 | Direct | 30,000 |
Reported balance
After 2022-06-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-23 · Grant · Acquired 30,000 · Balance 30,000 F4: The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.
F2: Each RSU represents a contingent right to receive one share of Issuer common stock
F3: Represents 4,389 shares of common stock and 10,000 restricted stock units
F4: The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.
Merck & Co., Inc.
Report date February 22, 2016 · Filed February 24, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,759.3521 |
Reported balance
After 2016-02-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-02-22 · Grant · Acquired 14,557 · Balance 133,759.3521 F1: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards. F2: Holdings include shares acquired in dividend reinvestment transactions. |
| Common Stock - 401(k) PlanSEC Table I · non-derivative | IndirectBy 401(k) | 719.079 |
Reported balance
Holding disclosure · report date 2016-02-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 719.079 F3: Includes shares acquired and dividends earned through January 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Distribution of net after tax shares of common stock on satisfaction of performance share units granted on 03/29/2013. Performance shares were paid out at 105 percent of target awards.
F2: Holdings include shares acquired in dividend reinvestment transactions.
F3: Includes shares acquired and dividends earned through January 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.
PUBLIC SERVICE ENTERPRISE GROUP INC
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,933.239 |
Reported balance
After 2026-05-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 2,246 · Balance 11,933.239 F1: 2026 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: 2026 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors.
F2: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CDK Global, Inc.
Report date July 06, 2022 · Filed July 06, 2022
Section 16 reporting ended · disclosed 2022-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 1
1 source rowRow 1 · 2022-07-06 · Disposition to issuer · Disposed 31,684 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.67 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-06 · Disposition to issuer · Disposed 15,384 · Balance 0 F2: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest.
F2: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 5, 2026 19:12 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantCommon Stock | 2,246 | $80.15 | $180,016.90 |
DisclosureSEC source: 0001225208-26-004927 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,933.239 F1 · shares: 2026 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 201.508 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000028 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,748.066 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 20:26 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009713 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,649.627 F1 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:34 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 179.449 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000206 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,546.558 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:37 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 139.41 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000122 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,367.109 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015707 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,227.699 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 01, 2025 Filed May 2, 2025 18:46 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantCommon Stock | 2,289 | $78.66 | $180,052.74 |
DisclosureSEC source: 0001225208-25-004574 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,615.088 F1 · shares: 2025 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 20:06 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 87.462 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012069 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,347.699 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 68.367 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-001209 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,260.237 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:33 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 47.588 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025502 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,191.87 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:41 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 51.346 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020388 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,144.282 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:09 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016557 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,092.936 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 01, 2024 Filed May 2, 2024 21:00 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantCommon Stock | 2,579 | $69.81 | $180,039.99 |
DisclosureSEC source: 0001225208-24-005483 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,248.838 F1 · shares: 2024 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 23:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 26.426 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012898 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,098.936 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 18:47 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 21.479 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-001308 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,072.51 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 20:50 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 48.731 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025908 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,051.031 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:57 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 41.45 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020824 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,002.3 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:43 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016970 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,960.85 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 01, 2023 Filed May 2, 2023 22:53 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantCommon Stock | 2,851 | $63.14 | $180,012.14 |
DisclosureSEC source: 0001225208-23-005267 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,561.626 F1 · shares: 2023 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 20:37 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 22.836 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013138 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,541.85 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 21:39 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 25.055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-001397 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,519.014 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:19 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-025760 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,493.959 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 23:21 UTC | CDK Global, Inc. CDK · Entity 125554 | Disposition to issuerOption (right to buy) · Derivative | 15,384 | Not disclosed Strike: $39.67 | Not disclosed |
DisclosureSEC source: 0000950142-22-002131 · es220267537_4-deese.xml · derivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,384 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 23:21 UTC | CDK Global, Inc. CDK · Entity 125554 | Disposition to issuerCommon Stock | 31,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-22-002131 · es220267537_4-deese.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and, at the effective time of the Merger, each share of common stock, par value $0.01 per share (each, a "Share"), of the Company was canceled and converted into the right to receive $54.87 in cash without interest. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:51 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001562180-22-005352 · primarydocument.xml · derivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-06-23 F4 · derivative.exercise_date: The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:51 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005352 · primarydocument.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,389 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director. F2 · price: Each RSU represents a contingent right to receive one share of Issuer common stock F3 · balance_after: Represents 4,389 shares of common stock and 10,000 restricted stock units Read SEC document |
| May 23, 2022 Filed May 25, 2022 21:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,900 | $0.00 Strike: $38.02 | $0.00 |
DisclosureSEC source: 0001127602-22-015678 · form4.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,900 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person exercised the reported stock options, which would have expired on May 23, 2022, and holds the underlying net common stock upon exercise. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 23, 2022 Filed May 25, 2022 21:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 6,814 | $38.50 | $262,339.00 |
DisclosureSEC source: 0001127602-22-015678 · form4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,111.959 Read SEC document |
| May 23, 2022 Filed May 25, 2022 21:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 6,900 | $38.02 | $262,338.00 |
DisclosureSEC source: 0001127602-22-015678 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,925.959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person exercised the reported stock options, which would have expired on May 23, 2022, and holds the underlying net common stock upon exercise. Read SEC document |
| May 02, 2022 Filed May 4, 2022 13:18 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantCommon Stock | 2,615 | $68.85 | $180,042.75 |
DisclosureSEC source: 0001225208-22-006412 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,615 F1 · shares: 2022 Restricted Stock Unit grant under the PSEG 2021 Equity Compensation Plan For Outside Directors. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:26 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7.609 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011838 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,025.959 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 22:00 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.952 | $0.00 | $0.00 |
DisclosureSEC source: 0001328766-22-000001 · primary_doc.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,018.35 F1 · shares: Represents dividends on Restricted Stock Units (RSUs) awarded to Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 23:31 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 4,761 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-21-003739 · es210203277_4-deese.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,684 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 11, 2022 and the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuer's board of directors. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:41 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.523 | $60.01 | $331.44 |
DisclosureSEC source: 0001127602-21-026964 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,012.398 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 20:48 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.156 | $64.18 | $330.91 |
DisclosureSEC source: 0001127602-21-021885 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,006.875 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:05 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantStock Options (Right to Buy) · Derivative | 19,620 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001562180-21-004392 · primarydocument.xml · derivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,620 Underlying: Common Stock · 19,620 shares Expires 2031-06-17 F3 · derivative.exercise_date: The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:05 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantCommon Stock | 4,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004392 · primarydocument.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,389 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director. F2 · price: Each RSU represents a contingent right to receive one share of Issuer common stock Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:29 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018503 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,001.719 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:58 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 2,121 | $63.65 | $135,001.65 |
DisclosureSEC source: 0001225208-21-007496 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,345.231 Underlying: Common Stock · 2,121 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the PSEG 2021 Equity Compensation Plan For Outside Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 21:17 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7.828 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013645 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,993.719 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 9.24 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001490 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,985.891 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,600 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0001127602-20-029926 · form4.xml · derivative · entry 5 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,600 shares Expires 2021-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $36.62 | $0.00 |
DisclosureSEC source: 0001127602-20-029926 · form4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2021-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 10,100 | $50.50 | $510,060.10 |
DisclosureSEC source: 0001127602-20-029926 · form4.xml · nonDerivative · entry 3 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,976.651 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.50 to $50.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 7,600 | $38.57 | $293,132.00 |
DisclosureSEC source: 0001127602-20-029926 · form4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,076.651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 2,500 | $36.62 | $91,550.00 |
DisclosureSEC source: 0001127602-20-029926 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,476.651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 23:33 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 4,005 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-20-002549 · es200113380_4-deese.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,923 F1 · shares: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in full at the earlier of November 12, 2021 and the Issuer's next annual meeting of stockholders. Upon vesting these Restricted Stock Units will be deferred and settled in shares of the Issuer's common stock 180 days after the date the Reporting Person ceases to be a member of the Issuer's board of directors. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 19:13 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11.015 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026844 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,976.651 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 10, 2020 Filed Jul 10, 2020 20:51 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11.053 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021348 · form4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965.636 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:37 UTC | G1 Therapeutics, Inc. GTHX · Entity 87413 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $17.59 | $0.00 |
DisclosureSEC source: 0001209191-20-036295 · doc4.xml · derivative · entry 1 Deese Willie A · CIK 0001328766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.